| Biotechnology Industry | Healthcare Sector | Dr. Bernard Courtieu DVM, MBA CEO | XPAR Exchange | FR0010908723 ISIN |
| France Country | 55 Employees | - Last Dividend | - Last Split | - IPO Date |
IntegraGen SA is a company specialized in providing comprehensive sequencing solutions, data management tools, and extensive support in biostatistics and bioinformatics primarily to researchers in France. The company's focus spans several genomic services including transcriptomics, epigenomics, DNA sequencing, and more, tailored towards cancer research, clinical research, agrigenomics, and microbial genomics. Established in 2000 with its headquarters in Évry, France, IntegraGen SA has expanded its reach and expertise over the years, now operating as a subsidiary of OncoDNA SA. The company is deeply committed to advancing research and clinical outcomes through state-of-the-art genomic services and innovative software solutions.
IntegraGen SA offers a wide array of genomic services such as transcriptomics, epigenomics, DNA sequencing, NGS testing for cancer research, and SNP genotyping. These services are designed to support researchers in uncovering genetic insights and advancing their scientific discoveries.
The company provides clinical grade sequencing and pharmacogenomics among other services, aimed at facilitating clinical research. This includes basic and human genetic research, supporting the development of personalized medicine and enhancing drug efficacy and safety.
IntegraGen SA extends its expertise to the field of agrigenomics, offering services such as crop and livestock genotyping and high-throughput sequencing tailored for agriculture. These services help in enhancing crop production, livestock management, and overall agricultural productivity.
Comprehensive microbial genomics services are available, including whole-genome microbial sequencing and microbial transcriptomics. These services assist researchers in studying microbial communities, understanding their functions, and exploiting their capabilities for various applications.
An online biological interpretation tool focused on oncology that assists pathologists and oncologists in converting raw data from high-throughput sequencing into comprehensive molecular reports. This tool is aimed at facilitating translational and clinical research in oncology.
A cloud-based software tool that enables the analysis of whole genome, whole exome, and gene panel sequencing data. SIRIUS is designed to streamline the genomic data analysis process, making it more accessible for researchers and clinicians.
This cloud-based application offers dynamic exploration of RNA-Seq expression data, providing researchers with advanced tools for the analysis and interpretation of gene expression patterns.
A genomic consulting service that grants researchers access to biostatistics and bioanalytics experts. GeCo is aimed at enhancing research outcomes by offering expert guidance in the analysis and interpretation of complex genomic data.